Attention Deficit Hyperactivity Disorder Therapeutics Market 2022
The global Attention Deficit Hyperactivity Disorder Therapeutics Market is expected to grow at a stupendous rate In Upcoming Years. Today calls for prediction tools that are powered by AI to optimize the usage of the resources available. This could also help in crisis management. As such, key market participants are likely to invest in predictive analytics for condoning unforeseen circumstances. These would be preventive steps taken by the enterprises on the whole.
The global attention deficit hyperactivity disorder therapeutics market is estimated to be worth US$ 22.5 Bn in the year 2022.The attention deficit hyperactivity disorder therapeutics market is expected to grow twofold between 2021 and 2031.The attention deficit hyperactivity disorder therapeutics market witnessed a CAGR of 6% between 2021 and 2031.
Get Free Sample Copy@ https://www.persistencemarketresearch.com/samples/4222
Both, stimulants and non-stimulants are gaining significant demand for the treatment of attention-deficit hyperactivity disorder. ADHD is one of the most common childhood disorders, and is more prevalent in males than females. ADHD is a chronic condition where treatment cannot cure the patient; however, early diagnosis and treatment could mitigate the symptoms. There are many effective ADHD therapeutics available, such as stimulants, amphetamine, and methylphenidate, which are generally selected by physicians for first medication. Besides, manufacturers are also continuously focusing on the development of new ADHD therapeutics with a diversity of mechanisms and functions.
The global attention-deficit hyperactivity disorder (ADHD) therapeutics market was valued at US$ 19 Bn in 2020, and is expected to witness a CAGR of 7% during the forecast period (2020–2030).
Switch Over To The “Methodology” Tab@ https://www.persistencemarketresearch.com/methodology/31378
Key Takeaways of ADHD Therapeutics Market Study
- Stimulants, under drug type, occupied above 86% of the market value share in the attention-deficit hyperactivity disorder therapeutics market in 2019, owing to their increasing adoption by physicians and parents for the treatment of ADHD.
- The adults segment, under age group, accounted for the highest market value share in global ADHD therapeutics market, as ADHD disorder is likely to be found more in adults than pediatric and adolescents.
- Retail pharmacies hold a major share in the global ADHD therapeutics market, owing to the high availability of ADHD drugs and ease of access.
- North America holds a prominent revenue share in the global attention-deficit hyperactivity disorder therapeutics market, due to the presence of established players in the region.
“Growing prevalence of ADHD disorder and increasing preference for cheaper and effective generic ADHD drugs are expected to boost the ADHD therapeutics market over the coming years,” says a PMR analyst.
Introduction of Innovative Drugs: Key Strategy of Leading Manufacturers
Manufacturers of generic drug are focusing on the introduction of cheaper and effective generic ADHD drugs to increase their market share. These generic drugs can cost several times lower than branded drugs, are equally safe, and of good quality and performance. Therefore, leaders in the global attention-deficit hyperactivity disorder therapeutics market are now looking forward to developing more generic drugs instead of branded ADHD drugs at a high cost. For instance, in March 2019, ANI Pharmaceuticals, Inc. announced the launch of 18mg and 27mg methylphenidate hydrochloride extended-release tablets for the treatment of ADHD.
Go To Purchase Now@ https://www.persistencemarketresearch.com/checkout/31378
More Valuable Insights on ADHD Therapeutics Market
Persistence Market Research offers a unique perspective and actionable insights on the attention-deficit hyperactivity disorder therapeutics market in its latest study, presenting historical demand assessment of 2015–2019 and projections for 2020–2030, on the basis of drug type (stimulants and non-stimulants), age group (pediatric & adolescents and adults), and distribution channel (hospital pharmacies, speciality clinics, retail pharmacies, and e-Commerce), across five major regions.
About PersistenceMarketResearch:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353